175 related articles for article (PubMed ID: 27185213)
1. Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation.
Sun J; Shen R; Schrock MS; Liu J; Pan X; Quimby D; Zanesi N; Druck T; Fong LY; Huebner K
Cancer Med; 2016 Aug; 5(8):2032-42. PubMed ID: 27185213
[TBL] [Abstract][Full Text] [Related]
2. Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.
Sun J; Liu J; Pan X; Quimby D; Zanesi N; Druck T; Pfeifer GP; Croce CM; Fong LY; Huebner K
Carcinogenesis; 2011 Mar; 32(3):351-8. PubMed ID: 21097531
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K
Cancer Res; 2005 Aug; 65(15):6576-82. PubMed ID: 16061637
[TBL] [Abstract][Full Text] [Related]
4. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
5. Nit1 and Fhit tumor suppressor activities are additive.
Sun J; Okumura H; Yearsley M; Frankel W; Fong LY; Druck T; Huebner K
J Cell Biochem; 2009 Aug; 107(6):1097-106. PubMed ID: 19479888
[TBL] [Abstract][Full Text] [Related]
6. Fragile histidine triad gene and skin cancer.
Zanesi N; Croce CM
Eur J Dermatol; 2001; 11(5):401-4. PubMed ID: 11525944
[TBL] [Abstract][Full Text] [Related]
7. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
8. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
[TBL] [Abstract][Full Text] [Related]
9. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
10. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
Kitamura A; Yashima K; Okamoto E; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Kaibara N; Kawasaki H
Oncology; 2001; 61(3):205-11. PubMed ID: 11574776
[TBL] [Abstract][Full Text] [Related]
11. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract][Full Text] [Related]
12. A Fhit-ing role in the DNA damage checkpoint response.
Ishii H; Wang Y; Huebner K
Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
14. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.
D'Arca D; LeNoir J; Wildemore B; Gottardo F; Bragantini E; Shupp-Byrne D; Zanesi N; Fassan M; Croce CM; Gomella LG; Baffa R
Urol Oncol; 2010; 28(2):189-94. PubMed ID: 19372053
[TBL] [Abstract][Full Text] [Related]
15. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
16. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
17. Fhit and CHK1 have opposing effects on homologous recombination repair.
Hu B; Wang H; Wang X; Lu HR; Huang C; Powell SN; Huebner K; Wang Y
Cancer Res; 2005 Oct; 65(19):8613-6. PubMed ID: 16204026
[TBL] [Abstract][Full Text] [Related]
18. Influence of a nonfragile FHIT transgene on murine tumor susceptibility.
McCorkell KA; Mancini R; Siprashvili Z; Barnoski BL; Iliopoulos D; Siracusa LD; Zanesi N; Croce CM; Fong LY; Druck T; Huebner K
Cytogenet Genome Res; 2007; 118(2-4):196-203. PubMed ID: 18000371
[TBL] [Abstract][Full Text] [Related]
19. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
